一种用于肾脏保护的口腔细菌混合物。
An oral bacterial cocktail for kidney protection.
作者信息
Jarman John, Dodd Dylan
机构信息
Department of Pathology, Stanford University, Stanford, CA, USA.
Department of Microbiology & Immunology, Stanford University, Stanford, CA, USA.
出版信息
Nat Biomed Eng. 2020 Sep;4(9):847-848. doi: 10.1038/s41551-020-00610-y.
Abstract
The oral delivery of a microencapsulated bacterial cocktail into animal models of kidney disease promotes the degradation of nitrogenous waste in the gut, thereby supporting renal function.
摘要
将微囊化细菌混合物经口服给予肾病动物模型，可促进肠道中含氮废物的降解，从而维持肾功能。
相似文献
1
An oral bacterial cocktail for kidney protection.一种用于肾脏保护的口腔细菌混合物。
Nat Biomed Eng. 2020 Sep;4(9):847-848. doi: 10.1038/s41551-020-00610-y.
2
An encapsulated bacterial cocktail for the removal of nitrogenous metabolic waste.一种用于去除含氮代谢废物的包囊化细菌混合物。
Nat Rev Nephrol. 2020 Sep;16(9):485. doi: 10.1038/s41581-020-0331-4.
3
An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure.一种口服微生物混合物，用于清除肾衰竭动物模型中的氮代谢废物。
Nat Biomed Eng. 2020 Sep;4(9):853-862. doi: 10.1038/s41551-020-0582-1. Epub 2020 Jul 6.
4
Extrarenal azotemia and functional renal failure.肾外性氮质血症和功能性肾衰竭。
Harefuah (Tel Aviv). 1945 Sep;52:3-14.
5
Protection against cisplatin lethality and renal toxicity by chlorpromazine in mice.
Ren Fail. 1994 Nov;16(6):681-6. doi: 10.3109/08860229409044897.
6
Postnephrectomy renal failure in a patient with a normal preoperative blood nonprotein nitrogen.术前血非蛋白氮正常的患者肾切除术后肾衰竭
Am J Med. 1956 Jan;20(1):157-8. doi: 10.1016/0002-9343(56)90183-8.
7
[The electrocardiographic picture in hyperazotemia due to renal failure].[肾衰竭所致高氮血症的心电图表现]
G Clin Med. 1948 Apr;29(4):328-47.
8
[RAPID LABORATORY DIAGNOSIS OF RENAL INSUFFICIENCY IN CLINICAL PRACTICE AND IN THE HOSPITAL].[临床实践及医院中肾功能不全的快速实验室诊断]
Ther Ggw. 1963 Jul;102:810-5.
9
NITROGEN METABOLISM IN RENAL FAILURE.肾衰竭中的氮代谢
Bull Postgrad Comm Med Univ Syd. 1964 May;20:51-7.
10
RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS.肝硬化患者的肾衰竭。I. 临床和病理特征。
Am J Med. 1965 Aug;39:184-98. doi: 10.1016/0002-9343(65)90041-0.
本文引用的文献
1
Microbial Contribution to the Human Metabolome: Implications for Health and Disease.微生物对人类代谢组的贡献：对健康和疾病的影响。
Annu Rev Pathol. 2020 Jan 24;15:345-369. doi: 10.1146/annurev-pathol-020117-043559. Epub 2019 Oct 17.
2
Chronic kidney disease and the gut microbiome.慢性肾脏病与肠道微生物群
Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1211-F1217. doi: 10.1152/ajprenal.00298.2018. Epub 2019 Mar 13.
3
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.特定共生菌群可诱导 CD8+T 细胞及抗肿瘤免疫。
Nature. 2019 Jan;565(7741):600-605. doi: 10.1038/s41586-019-0878-z. Epub 2019 Jan 23.
4
An engineered Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans.工程化 Nissle 可改善高血氨症和小鼠的存活率，并在健康人群中表现出剂量依赖性暴露。
Sci Transl Med. 2019 Jan 16;11(475). doi: 10.1126/scitranslmed.aau7975.
5
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria.开发一种用于人类代谢疾病苯丙酮尿症的合成活菌治疗方法。
Nat Biotechnol. 2018 Oct;36(9):857-864. doi: 10.1038/nbt.4222. Epub 2018 Aug 13.
6
Engineering the gut microbiota to treat hyperammonemia.通过工程改造肠道微生物群来治疗高氨血症。
J Clin Invest. 2015 Jul 1;125(7):2841-50. doi: 10.1172/JCI79214. Epub 2015 Jun 22.
7
Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art.海藻酸盐颗粒作为口服给药平台：最新进展
ISRN Pharm. 2014 Apr 9;2014:926157. doi: 10.1155/2014/926157. eCollection 2014.
8
Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis.粪便灌肠作为伪膜性小肠结肠炎治疗的辅助手段。
Surgery. 1958 Nov;44(5):854-9.
9
Nitrogen metabolism in the gut.肠道中的氮代谢。
Am J Clin Nutr. 1978 Sep;31(9):1587-93. doi: 10.1093/ajcn/31.9.1587.
Zotero 插件